Intellectia LogoIntellectia
Product
Resources
Markets
News
Partner Program
Pricing
Log inTry for Free
Intellectia Logo
Log in
Intellectia Logo

Product

Features
Financial AI Agent
Stock Technical Analysis
Stock Monitor
Hedge Fund Tracker
AI Screener
Trading Strategies
AI Stock Picker
Swing Trading
Quant AI
Stock Chart Patterns
Daytrading Center
AI Earnings Prediction
Whales Auto Tracker
Backtesting Playground

Resources

Learn
Blog
Earnings
Tutorial
Help Center
Company
About Us
Contact
Press
Reward Program
Partner Program
Tools
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Compare
TradingView
SeekingAlpha

Markets

Trending Stocks
Hot Crypto
Trending News
All Stocks

News

Trading News
Overview
Top News
Daily Market Brief
Earnings
Latest
Newswire
Stock News
Crypto News
Monitor News
Partner ProgramPricing
Start for Free
  1. Home
    2. >
  2. Stock
    3. >
  3. AMWL
stocks logo

AMWL

-
collectAdd to Watchlistadvanced chartAdvanced Chart
$
0.000
0(0.000%)1D
collectadvanced chart
    Overview
    Forecast
    Valuation
    Earnings
High
--
Open
--
VWAP
--
Vol
--
Mkt Cap
--
Low
--
Amount
--
EV/EBITDA(TTM)
--
Total Shares
--
EV
--
EV/OCF(TTM)
--
P/S(TTM)
--
AI Stock Picker
AI Stock Picker

Market Estimates

Earnings Estimates
Earnings Estimates
Revenue
YoY Chg
EPS
YoYChg
FY2025Q4
FY2026Q1
FY2026Q2
52.71M
-25.77%
-1.780
-35.74%
57.82M
-13.48%
-1.335
+12.18%
58.01M
-18.17%
-1.262
+1.75%
Estimates Revision
The market is revising Downward the revenue expectations for American Well Corporation (AMWL) for FY2025, with the revenue forecasts being adjusted by -0.37% over the past three months. During the same period, the stock price has changed by -40.97%.
Revenue Estimates for FY2025
Revise Downward
down Image
-0.37%
In Past 3 Month
EPS Estimates for FY2025
Revise Upward
up Image
+0.25%
In Past 3 Month
Stock Price
Go Down
down Image
-40.97%
In Past 3 Month
Wall Street analysts forecast AMWL stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for AMWL is 8.83 USD with a low forecast of 7.00 USD and a high forecast of 12.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
5 Analyst Rating
Wall Street analysts forecast AMWL stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for AMWL is 8.83 USD with a low forecast of 7.00 USD and a high forecast of 12.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
1 Buy
4 Hold
0 Sell
Hold
Current: 4.120
sliders
Low
7.00
Averages
8.83
High
12.00
Current: 4.120
sliders
Low
7.00
Averages
8.83
High
12.00
Stifel
Hold
downgrade
$8 -> $6
2025-11-05
Reason
Stifel
Price Target
$8 -> $6
2025-11-05
downgrade
Hold
Reason
Stifel lowered the firm's price target on Amwell to $6 from $8 and keeps a Hold rating on the shares. While the company's execution on cost takeout and the DHA contract launch have been positive, visibility remains limited on several fronts, the analyst tells investors in a post-earnings note.
TD Cowen
Hold
downgrade
$10 -> $7
2025-11-05
Reason
TD Cowen
Price Target
$10 -> $7
2025-11-05
downgrade
Hold
Reason
TD Cowen lowered the firm's price target on Amwell to $7 from $10 and keeps a Hold rating on the shares. The firm said its 3Q adj. EBITDA beat/raise and reiterating '26 CF breakeven target are positive for cost reduction priorities.
TD Cowen
Hold
downgrade
$12 -> $10
2025-08-06
Reason
TD Cowen
Price Target
$12 -> $10
2025-08-06
downgrade
Hold
Reason
TD Cowen lowered the firm's price target on Amwell to $10 from $12 and keeps a Hold rating on the shares. The firm updated its model following Q2 results but said while the DHA extension is a positive, its reduced scope which excludes Behavioral health and automated care, is an unfortunate development.
Piper Sandler
Neutral
downgrade
$10 -> $8
2025-05-23
Reason
Piper Sandler
Price Target
$10 -> $8
2025-05-23
downgrade
Neutral
Reason
Piper Sandler lowered the firm's price target on Amwell to $8 from $10 and keeps a Neutral rating on the shares following a positive Q1 print where the company beat revenue and adjusted EBITDA guidance and reaffirmed the 2025 outlook. As of early April, scheduled visits are live across the entire DHA; a considerable achievement delivered on time and on budget, the firm notes. DHA patient and provider satisfaction levels are running in excess of 90.0%. However, due to a leadership transition at the DHA, enterprise-wide deployments of automated programs and digital behavioral health planned for Q2 are expected to be delayed until Q3, Piper says.
UBS
Kevin Caliendo
Neutral
downgrade
$12 -> $9
2025-05-08
Reason
UBS
Kevin Caliendo
Price Target
$12 -> $9
2025-05-08
downgrade
Neutral
Reason
UBS analyst Kevin Caliendo lowered the firm's price target on Amwell to $9 from $12 and keeps a Neutral rating on the shares.
Truist Securities
Jailendra Singh
Hold
Maintains
$12 → $7.5
2025-04-10
Reason
Truist Securities
Jailendra Singh
Price Target
$12 → $7.5
2025-04-10
Maintains
Hold
Reason
Truist lowered the firm's price target on Amwell to $7.50 from $12 and keeps a Hold rating on the shares as part of a broader research note previewing Q1 results in the Healthcare IT industry. The industry is typically shielded from macro uncertainty, but tariffs and concerns around an economic slowdown have created broader market uncertainty, which is never good for a high-beta highly volatile group like HCIT/Digital Health/Payviders, the analyst tells investors in a research note. Truist adds that while HCIT companies may not be directly exposed to new tariffs, several of these companies serve end markets - hospitals, pharma, etc. - which are likely to see either some direct impact on their supply chain costs or could decide to slow down on their investments.
See All Ratings

Valuation Metrics

The current forward P/E ratio for American Well Corp (AMWL.N) is -0.75, compared to its 5-year average forward P/E of -12.84. For a more detailed relative valuation and DCF analysis to assess American Well Corp 's fair value, click here.
  • Forward PE
  • Forward EV/EBITDA
  • Forward PS

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PE
-12.84
Current PE
-0.75
Overvalued PE
12.51
Undervalued PE
-38.18

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average EV/EBITDA
-4.26
Current EV/EBITDA
0.00
Overvalued EV/EBITDA
6.13
Undervalued EV/EBITDA
-14.66

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PS
4.45
Current PS
0.00
Overvalued PS
10.97
Undervalued PS
-2.07
Financial AI Agent
Financial AI Agent

Financials

Annual
Quarterly
N/A
Total Revenue
N/A
Operating Profit
N/A
Net Income after Tax
N/A
EPS - Diluted
N/A
Free Cash Flow
N/A
Gross Profit Margin - %
N/A
FCF Margin - %
N/A
Net Margin - %

Trading Trends

  • Insider
  • Hedge Fund
  • Congress Trading
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Hedge Fund
Hedge Funds are Neutral. There are no significant trading trends over the last quarter.
Sold
Bought
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Intellectia AI SwingMax
Intellectia AI SwingMax

AMWL News & Events

Events Timeline

(ET)
2025-11-04
17:48:14
Amwell adjusts FY25 revenue forecast downward to $245M-$248M from previous estimate of $245M-$250M.
select
2025-11-04
17:39:05
Amwell Projects Q4 Revenue Between $51M and $54M, Below Consensus of $55.53M
select
2025-11-04
17:36:41
Amwell Announces Q3 Earnings Per Share of $2.00, Exceeding Consensus Estimate of $1.46
select
Sign Up For More Events
Sign Up For More Events

News

[object Object]
Preview
9.5
11-05NASDAQ.COM
American Well (AMWL) Q3 Earnings: Analyzing Key Metrics Against Estimates

  • Quarterly Revenue and EPS: American Well Corporation (AMWL) reported $56.29 million in revenue for Q3 2025, a 7.8% decline year-over-year, with an EPS of -$1.74 compared to -$2.87 a year ago.

  • Surprise Metrics: The revenue exceeded the Zacks Consensus Estimate by 3.53%, while the EPS also surpassed expectations by 4.92%.

  • Investor Insights: Investors are advised to focus on key metrics that provide deeper insights into the company's performance, beyond just headline revenue and earnings figures.

  • Research Recommendations: Zacks Investment Research offers insights and recommendations, including a report on the "7 Best Stocks for the Next 30 Days."

[object Object]
Preview
9.5
10-28Newsfilter
Amwell® to Announce Q3 2025 Financial Results; Executives to Participate in Upcoming Investor Conferences

  • Earnings Report Announcement: Amwell will release its third quarter 2025 operating results on November 4, followed by a live conference call at 5 p.m. ET to discuss the results and provide a business update.

  • Investor Conferences Participation: CFO and COO Mark Hirschhorn will engage in one-on-one meetings at the UBS Global Healthcare Conference on November 11 and participate in a panel discussion at the BTIG Digital Health Forum on November 24.

  • Amwell's Healthcare Platform: The company offers a comprehensive, technology-enabled care platform that enhances patient access to affordable and effective healthcare, serving millions of patients and healthcare organizations globally.

  • Access to Webcast and Information: The earnings report and conference call can be accessed via the Investors section of Amwell's website, with a replay available for 90 days post-event.

[object Object]
Preview
2.0
08-13NASDAQ.COM
Hims & Hers Stock Plunges 21.3% in 3 Months: Time to Hold or Exit?

  • Stock Performance and Financial Results: Hims & Hers Health, Inc. has faced a decline of 21.3% in stock value recently, underperforming compared to industry peers, despite reporting strong growth in subscribers and online revenue in Q2 2025. The company anticipates significant revenue growth for the upcoming quarters but is challenged by rising product costs affecting gross margins.

  • Expansion and Strategic Initiatives: The company is expanding its personalized healthcare platform and geographic reach through acquisitions like ZAVA, while also launching new programs such as an affordable weight loss initiative in Canada. Hims & Hers aims to leverage AI for enhanced diagnostics and treatment plans, positioning itself for future growth despite current stock price challenges.

Sign Up For More News

People Also Watch

FAQ

arrow icon

What is American Well Corp (AMWL) stock price today?

The current price of AMWL is 4.12 USD — it has increased 0.98 % in the last trading day.

arrow icon

What is American Well Corp (AMWL)'s business?

American Well Corporation operates a hybrid care, delivery enablement platform in the United States and globally, connecting and enabling providers, payers, patients, and innovators to deliver access to more affordable quality care. It offers a single, comprehensive platform to support all digital health needs from urgent to acute and post-acute care, as well as chronic care management and healthy living. The Amwell Converge platform offers data architecture and video capabilities, flexibility and scalability, as well as a user experience focused on the needs of patients, members and providers. For health systems, its enterprise platform enables provider-to-provider virtual care for use cases ranging from stroke to virtual nursing and e-sitting. Its Amwell Carepoint devices enable healthcare providers to leverage proprietary carts and transform existing tablets and TVs into digital access points in clinical settings, helping to address personnel shortages and access limitations.

arrow icon

What is the price predicton of AMWL Stock?

Wall Street analysts forecast AMWL stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for AMWL is 8.83 USD with a low forecast of 7.00 USD and a high forecast of 12.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

arrow icon

What is American Well Corp (AMWL)'s revenue for the last quarter?

American Well Corp revenue for the last quarter amounts to 56.29M USD, decreased -7.80 % YoY.

arrow icon

What is American Well Corp (AMWL)'s earnings per share (EPS) for the last quarter?

American Well Corp. EPS for the last quarter amounts to -2.00 USD, decreased -30.31 % YoY.

arrow icon

What changes have occurred in the market's expectations for American Well Corp (AMWL)'s fundamentals?

The market is revising Downward the revenue expectations for American Well Corporation (AMWL) for FY2025, with the revenue forecasts being adjusted by -0.37% over the past three months. During the same period, the stock price has changed by -40.97%.
arrow icon

How many employees does American Well Corp (AMWL). have?

American Well Corp (AMWL) has 877 emplpoyees as of December 05 2025.

arrow icon

What is American Well Corp (AMWL) market cap?

Today AMWL has the market capitalization of 67.45M USD.

Intellectia LogoIntellectiaIntellectia LogoIntellectia

Redefine Your Investment Decisions

TwitterTwitterYoutubeYoutubeQuoraQuoraDiscordDiscordLinkedinLinkedinTelegramTelegram
AppStoreGooglePlay

Copyright © 2025 Intellectia.AI. All Rights Reserved.

pci certified logo
Company
HomeContactAbout UsNews Release
Compare
TradingViewSeeking Alpha
Features
Financial AI AgentStock Technical AnalysisStock MonitorHedge Fund TrackerAI ScreenerDaytrading Center
Strategies
AI Stock PickerSwing TradingStock Chart PatternsEarnings TradingDaytrading CenterAI Earnings PredictionQuant AIWhales Auto TrackerBacktesting Playground
Free Tools
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Resource
BlogTutorialEarningsTrending StocksCrypto MarketPartner ProgramTerms of UsePrivacy PolicySecuritySitemap
Start for Free